Association Between Distress at Diagnosis and Disease-free Survival Among Patients With Resectable Colon Cancer: A Large Cohort Study

被引:0
|
作者
Shin, Jung Kyong [1 ]
Kang, Danbee [2 ,3 ]
Kim, Soohyun [2 ,3 ]
Choi, Youngeun [1 ]
Lee, Woo Yong [1 ]
Yun, Seong Hyeon [1 ]
Cho, Yong Beom [1 ]
Huh, Jung Wook [1 ]
Park, Yoon Ah [1 ]
Cho, Juhee [2 ,3 ]
Kim, Hee Cheol [1 ]
机构
[1] Sungkyunkwan Univ, Samsung Med Ctr, Sch Med, Dept Surg, Seoul, South Korea
[2] Samsung Adv Inst Hlth Sci & Technol, Dept Clin Res Design & Evaluat, Seoul, South Korea
[3] Sungkyunkwan Univ, Ctr Clin Epidemiol, Samsung Med Ctr, Sch Med, Seoul, South Korea
关键词
colon cancer; distress at the diagnosis; oncologic outcomes; PALLIATIVE CARE; COLORECTAL-CANCER; STRESS; RECURRENCE; BREAST; CARCINOMA; MORTALITY;
D O I
10.1097/SLA.0000000000005791
中图分类号
R61 [外科手术学];
学科分类号
摘要
Objective:This study aimed to evaluate the association between distress at initial diagnosis and disease-free survival in patients with resectable colon cancer. Summary Background Data:Considerable research has examined the psychological impact of having a confirmed diagnosis of cancer, but relatively limited research has examined the impact of distress during the diagnostic phase on oncological outcomes. Methods:This is a retrospective cohort study. We included newly diagnosed colon cancer patients who had resectable surgery and underwent distress screening between July 2014 and July 2021 (N=1,362). The Korean versions of the Distress Thermometer were used to assess distress and related problems. Patients were categorized into 3 groups based on distress score: low (<4), moderate (4-7), and severe (& GE;8). The primary outcome was disease-free survival. Results:The mean distress was 5.1 (SD=2.4) and 61%, and 15% of patients had moderate and severe distress at diagnosis, respectively. The severe distress group was more likely to report fear, sadness, and concerns regarding insurance/finance, work, and childcare than the low distress group. Compared with the low distress group, the severe distress group had worse disease-free survival (Hazard Ratio=1.84, 95% CI=1.03, 3.29). The association was more evident in patients with stage IV disease (Hazard Ratio=2.53, 95% CI=1.02, 6.25). Conclusions:A substantial number of patients with colon cancer experience distress at diagnosis, and severe distress has a negative impact on oncologic outcomes. Active monitoring and appropriate management of distress at diagnosis should be adopted at clinical settings.
引用
收藏
页码:E534 / E539
页数:6
相关论文
共 50 条
  • [1] Conditional disease-free survival among patients with breast cancer
    Paik, Hyun-June
    Lee, Se Kyung
    Ryu, Jai Min
    Park, Sungmin
    Kim, Isaac
    Bae, Soo Youn
    Yu, Jonghan
    Lee, Jeong Eon
    Kim, Seok Won
    Nam, Seok Jin
    MEDICINE, 2017, 96 (01)
  • [2] Conditional disease-free survival among patients with breast cancer
    Paik, H. J.
    Lee, S. K.
    Ryu, J. M.
    Park, S.
    Yi, H. W.
    Bae, S. Y.
    Yu, J.
    Lee, J. E.
    Kim, S. W.
    Nam, S. J.
    EUROPEAN JOURNAL OF CANCER, 2016, 57 : S135 - S135
  • [3] Conditional disease-free survival among patients with breast cancer
    Paik, H-J
    Lee, S. K.
    Park, S.
    Ryu, J. M.
    Kim, I.
    Bae, S. Y.
    Yu, J.
    Lee, J. E.
    Kim, S. W.
    Nam, S. J.
    CANCER RESEARCH, 2017, 77
  • [4] Disease-free survival and the prognostic factors affecting disease-free survival in patients with medullary thyroid carcinoma: a multicenter cohort study
    Zuhur, Sayid Shafi
    Ozturk, Beyza Olcay
    Keskin, Umran
    Uysal, Serhat
    Hacioglu, Aysa
    Avci, Ugur
    Karsli, Seda
    Andac, Burak
    Ozbay, Umit Nur
    Kilinc, Faruk
    Erol, Selvinaz
    Catak, Merve
    Sodan, Hulyanur
    Pekkolay, Zafer
    Burhan, Sebnem
    Akbaba, Gulhan
    Ates, Coskun
    Yorulmaz, Goknur
    Tekin, Sakin
    Topcu, Birol
    Tuna, Mazhar Muslum
    Kadioglu, Pinar
    Gonen, Mustafa Sait
    Karaca, Zuleyha
    Ciftci, Sema
    Celik, Mehmet
    Guldiken, Sibel
    Tuzun, Dilek
    Altuntas, Yuksel
    Akturk, Mujde
    Niyazoglu, Mutlu
    Cinar, Nese
    Gul, Ozen Oz
    Kebapci, Medine Nur
    Akalin, Aysen
    Bayraktaroglu, Taner
    Elbuken, Gulsah
    ENDOCRINE, 2024, 85 (03) : 1300 - 1309
  • [5] Prognosis and Conditional Disease-Free Survival Among Patients With Ovarian Cancer
    Kurta, Michelle L.
    Edwards, Robert P.
    Moysich, Kirsten B.
    McDonough, Kathleen
    Bertolet, Marnie
    Weissfeld, Joel L.
    Catov, Janet M.
    Modugno, Francesmary
    Bunker, Clareann H.
    Ness, Roberta B.
    Diergaarde, Brenda
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (36) : 4102 - U327
  • [6] Prognosis and conditional disease-free survival among ovarian cancer patients
    Kurta, Michelle
    Edwards, Robert
    Moysich, Kirsten
    McDonough, Kathleen
    Bertolet, Marnie
    Weissfeld, Joel
    Catov, Janet
    Modugno, Francesmary
    Bunker, Clareann
    Ness, Roberta
    Diergaarde, Brenda
    CANCER RESEARCH, 2014, 74 (19)
  • [7] Racial disparities in disease-free and overall survival among colorectal cancer patients in the prospective ColoCare cohort
    Jean-Baptiste, Esther
    Ilozumbo, Mmadili
    Rouhani, Gazelle
    Gomez, Maria F.
    Hogue, Stephanie R.
    Hardikar, Sheetal
    Gigic, Biljana
    Li, Christopher I.
    Figueiredo, Jane C.
    Toriola, Adetunji T.
    Ulrich, Cornelia M.
    Shibata, David
    Siegel, Erin M.
    Byrd, Doratha A.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2024, 33 (09)
  • [8] Identification and initial validation of maximal tumor area as a novel prognostic factor for overall and disease-free survival in patients with resectable colon cancer: a retrospective study
    Ning, Fei-Long
    Gu, Wan-Jie
    Dai, Lin-Zheng
    Du, Wan-Ying
    Zeng, Yong-Ji
    Zhang, Jia-Kui
    Abe, Masanobu
    Liu, Yan-Long
    Zhang, Rui
    Zhang, Chun-Dong
    INTERNATIONAL JOURNAL OF SURGERY, 2023, 109 (11) : 3407 - 3416
  • [9] Neoadjuvant chemotherapy for borderline resectable and upfront resectable pancreatic cancer increasing overall survival and disease-free survival?
    Fossaert, Violette
    Mimmo, Antonio
    Rhaiem, Rami
    Rached, Linda J.
    Brasseur, Mathilde
    Brugel, Mathias
    Pegoraro, Francesca
    Sanchez, Stephane
    Bouche, Olivier
    Kianmanesh, Reza
    Piardi, Tullio
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [10] Association Between Travel Distance and Metastatic Disease at Diagnosis Among Patients With Colon Cancer
    Massarweh, Nader N.
    Chiang, Yi-Ju
    Xing, Yan
    Chang, George J.
    Haynes, Alex B.
    You, Y. Nancy
    Feig, Barry W.
    Cormier, Janice N.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (09) : 942 - +